Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES (ABT)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales20 40520 85327 39031 08132 94134 964
EBITDA4 8504 9757 0227 6678 4449 567
Operating profit (EBIT)3 9794 1725 9766 4586 9557 903
Pre-Tax Profit (EBT)------
Net income4 4231 4004772 5363 2483 415
P/E ratio15,440,921145,031,928,6
EPS ( $ )2,920,940,271,301,842,05
Dividend per Share ( $ )0,981,041,061,121,201,29
Yield2,18%2,71%1,86%1,90%2,04%2,19%
Reference price ( $ )44.9138.4157.0758.6558.6558.65
Announcement Date01/28/2016
12:31pm
01/25/2017
12:45pm
01/24/2018
12:45pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt2 8763 23118 31415 15212 6089 416
Finance------
Operating income (EBITDA)4 8504 9757 0227 6678 4449 567
Leverage
(Debt/EBITDA)
0,59x0,65x2,61x1,98x1,49x0,98x
Capital Expenditure1 1101 1211 1351 2271 2761 189
Book Value Per Share (BVPS)14,4 $13,9 $17,7 $18,2 $19,2 $20,6 $
Cash Flow per Share1,97 $2,16 $3,18 $2,78 $3,30 $3,41 $
Announcement Date01/28/2016
12:31pm
01/25/2017
12:45pm
01/24/2018
12:45pm
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 101 829 M$ -
Entreprise Value (EV) 116 981 M$ 114 437 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 45,0x 31,9x
Capitalization / Revenue 3,28x 3,09x
EV / Revenue 3,76x 3,47x
EV / EBITDA 15,3x 13,6x
Yield (DPS / Price) 1,90% 2,04%
Price to book (Price / BVPS) 3,21x 3,05x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 20,8% 21,1%
operating Leverage (Delta EBIT / Delta Sales) 0,60x 1,29x
Net Margin (Net Profit / Revenue) 8,16% 9,86%
ROA (Net Profit / Asset) 5,57% 6,73%
ROE (Net Profit / Equities) 14,3% 15,5%
Rate of Dividend 85,7% 65,2%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   3,95% 3,87%
Cash Flow / Sales 15,6% 17,5%
Capital Intensity (Assets / Sales) 1,47x 1,46x
Financial Leverage (Net Debt / EBITDA) 1,98x 1,49x
EPS & Dividend